The proteasome inhibitor bortezomib inhibits the release of NF kappa B-inducible cytokines and induces apoptosis of activated T cells from rheumatoid arthritis patients

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)92-98
JournalClinical and Experimental Rheumatology
Volume27
Issue number1
Publication statusPublished - 2009

Cite this